| Flixy Smart TV Stick Claims Evaluated: The Most Recommended TV Streaming Stick Device Without Costly Subscriptions |
Globe Newswire |
04/17 |
17:46 |
| Arbe Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency |
Globe Newswire |
04/17 |
17:20 |
| Rocket Doctor Amends 45 Degree Agreement |
Globe Newswire |
04/17 |
17:18 |
| Keeps Hair Growth Product Claims Evaluated: Topical & Oral RX Hair Loss Prescription Treatment with Finasteride, Dutasteride & Minoxidil |
Globe Newswire |
04/17 |
17:01 |
| Lincoln Educational Services Corporation Schedules First Quarter 2026 Earnings Release And Conference Call |
Globe Newswire |
04/17 |
16:20 |
| BGIN BLOCKCHAIN LIMITED Schedules the Fiscal Year 2025 Earnings and Conference Call on April 24, 2026 |
Globe Newswire |
04/17 |
16:15 |
| TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call |
Globe Newswire |
04/17 |
16:10 |
| SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders |
Globe Newswire |
04/17 |
16:05 |
| Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types |
Globe Newswire |
04/17 |
16:01 |
| Hingham Savings Reports First Quarter 2026 Results |
Globe Newswire |
04/17 |
16:01 |
| New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer |
Globe Newswire |
04/17 |
16:01 |
| Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting |
Globe Newswire |
04/17 |
16:01 |
| Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2 |
Globe Newswire |
04/17 |
16:01 |
| Long Beach City College Wins Regional Construction Awards for Campus Upgrades |
Globe Newswire |
04/17 |
15:58 |
| Genesis Revival Claims Evaluated: Analyzing the Pineal Gland Support Ingredients, Side Effects Risk and User Complaints |
Globe Newswire |
04/17 |
15:48 |
| Introspect Technology Adds New ATE-on-Bench Solution for LPDDR6, DDR6, and HBM Interfaces |
Globe Newswire |
04/17 |
15:35 |
| Action Target Announces Registration Is Open for 34th Annual Law Enforcement Training Camp (LETC) |
Globe Newswire |
04/17 |
15:19 |
| Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026 |
Globe Newswire |
04/17 |
15:15 |
| Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial |
Globe Newswire |
04/17 |
15:10 |
| Kairos Power Breaks Ground on Hermes 2 Demonstration Plant |
Globe Newswire |
04/17 |
15:06 |
| Biolojic Design Presents New Preclinical Data for BD200, a First-in-Class Multibody-Drug Conjugate Targeting Trop-2 and Nectin-4 at the American Association of Cancer Research Annual Meeting |
Globe Newswire |
04/17 |
15:00 |
| New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma |
Globe Newswire |
04/17 |
15:00 |
| PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma |
Globe Newswire |
04/17 |
15:00 |
| Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026 |
Globe Newswire |
04/17 |
15:00 |
| Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform |
Globe Newswire |
04/17 |
15:00 |
